Phage treatment for antibiotic-resistant urinary tract infections
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether specially designed viruses (called phages) can safely and effectively treat drug-resistant urinary tract infections. The phages are delivered directly into your bladder or kidney through a small tube, and the goal is to eliminate the infection when standard antibiotics have failed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a urinary tract infection caused by bacteria that resist many antibiotics (or that don't clear up with standard antibiotics).
- Standard antibiotics either haven't worked, you're allergic, or they'd be too toxic for you.
- You must be able to tolerate having a catheter or tube placed to deliver the treatment directly to your bladder or kidney.
- You must not have a blocked urinary tract or an abscess that cannot be drained.
- Your kidney function must be reasonably good (not severely impaired).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether fosfomycin works better than the usual treatment for children with urine infections caused by antibiotic-resistant germs. It may help by using an antibiotic choice that can still work when common oral options may fail.
This trial tests a phage (virus that kills bacteria) treatment for women who have had a kidney transplant and keep getting urinary tract infections (UTIs) caused by E. coli bacteria. It aims to see if this therapy can help prevent future infections.
This trial tests whether a special virus (bacteriophage) that attacks E. coli bacteria can help control bacteria in the bladder without causing an infection. It's for people with spinal cord injury who use a catheter and have E. coli in their urine but no active infection.
This trial studies using phages (viruses that attack bacteria) to treat infections that have not improved with other treatments. It aims to see if this patient-specific approach works and what it costs.
This trial tests a treatment using viruses that attack bacteria to fight a chronic infection in a joint replacement. It might help people whose joint infection has not cleared up with standard antibiotics or surgery.
This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.
Hear when a new Urinary Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.